Device Trial Radar · NCT03992768
Feature Detection Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System
Last checked: Nov 20, 2026Latest source record: Dec 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
540
Actual
Start
Jun 12, 2019
Primary completion
Sep 30, 2021
Study completion Sep 30, 2021
Sponsor
- Lead sponsor
- Hamamatsu Photonics K.K.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 20, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the repeatability and reproducibility of detection of histological features using whole slide imaging
Conditions
- Pathology
Interventions
Hamamatsu NanoZoomer S360MD Digital Slide Scanner SystemDevice
Detection of pathology features using whole slide imaging
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Percentage Agreement of Repeatability and Reproducibility Within Scanner, Between Scanners, and Sites.Time frame: 1 day
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Washington University
St Louis, Missouri
The Cleveland Clinic Foundation
Cleveland, Ohio
The Ohio State University
Columbus, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.